Cancer Vaccines Make a Comeback, as Third Rock Pumps $55M into Neon Therapeutics

Cancer vaccines got a bad name years ago. First, they don’t prevent cancer—they are supposed to stimulate the immune system to fight existing tumors. Early-generation cancer vaccines that made it to clinical trials couldn't stimulate enough immune firepower to kill tumors, cost too much to manufacture, or failed for other reasons.